Revenue
878 thousand USD
2012 Q3 · USD
Exact inputs and evidence
- Revenue: 878000 USD Source
Market value is not computed: no listed ticker is recorded for this company.
28 filing records in this dataset, filed from 2007-11-19 to 2012-11-06. Reported financial figures are available; chart coverage varies by period.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.
No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 1980-01-02 to 2026-11-20; this is not a statement that none were filed.
878 thousand USD
2012 Q3 · USD
-1,437.24%
2012 Q3 · %
-10.6 million USD
2012 Q3 · USD
114218000 USD
30586336 shares
1.31% · 397 thousand shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.
Latest filing recorded: 2012-11-06.
Financial data available through: 2011-12-31.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
−USD 54.67 million
–
Current period
−USD 32.94 million
–
-32939000 − -54673000 = 21734000 USD
-54673000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source-32939000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
−USD 49.36 million
–
Current period
USD 29.72 million
–
29717000 − -49363000 = 79080000 USD
-49363000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source29717000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 2.08 million
–
Current period
USD 1.75 million
–
1754000 − 2080000 = -326000 USD
2080000 USD · 2010-01-01 – 2010-12-31
Inspect prior input Prior source1754000 USD · 2011-01-01 – 2011-12-31
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2009 2009-01-01 – 2009-12-31 | 54166000 | 61135000 Derived | -6969000 | 2028000 Derived | -8997000 | -5324000 Derived | Source
|
| 2011 2011-01-01 – 2011-12-31 | 23069000 | 55723000 Derived | -32654000 | 285000 Derived | -32939000 | 27963000 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2009 | Revenue | 54166000 |
|
| 2011 | Revenue | 23069000 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Year over year | No prior comparable period |
|
| 2011 | Year over year | No prior comparable period |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Operating margin | -12.9% |
|
| 2011 | Operating margin | -141.5% |
|
| 2009 | Net margin | -16.6% |
|
| 2011 | Net margin | -142.8% |
|
| 2009 | Free cash flow margin | -9.8% |
|
| 2011 | Free cash flow margin | 121.2% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2009 | Operating cash flow | -4008000 |
|
| 2011 | Operating cash flow | 29717000 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2009 | Free cash flow | -5324000 |
|
| 2011 | Free cash flow | 27963000 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Liabilities / assets | 41.1% |
|
| 2011 | Liabilities / assets | 63.2% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2009 | Current assets / current liabilities | 3.05× |
|
| 2011 | Current assets / current liabilities | 7.09× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2004 2004-01-01 – 2004-12-31 | −USD 8.83 million Exact valueExact value: -8831000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2005 2005-01-01 – 2005-12-31 | −USD 16.25 million Exact valueExact value: -16249000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2006 2006-01-01 – 2006-12-31 | −USD 25.81 million Exact valueExact value: -25809000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2007 2007-01-01 – 2007-12-31 | −USD 40.06 million Exact valueExact value: -40060000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2008 2008-01-01 – 2008-12-31 | −USD 72.93 million Exact valueExact value: -72928000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2009 2009-01-01 – 2009-12-31 | −USD 9 million Exact valueExact value: -8997000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 4.01 million Exact valueExact value: -4008000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.32 million Exact valueExact value: 1316000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 5.32 million Calculation and evidence-4008000 − 1316000 USD Exact free cash flow: -5324000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2010 2010-01-01 – 2010-12-31 | −USD 54.67 million Exact valueExact value: -54673000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 49.36 million Exact valueExact value: -49363000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.08 million Exact valueExact value: 2080000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 51.44 million Calculation and evidence-49363000 − 2080000 USD Exact free cash flow: -51443000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2011 2011-01-01 – 2011-12-31 | −USD 32.94 million Exact valueExact value: -32939000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 29.72 million Exact valueExact value: 29717000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.75 million Exact valueExact value: 1754000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 27.96 million Calculation and evidence29717000 − 1754000 USD Exact free cash flow: 27963000 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
28 filings · 763 latest values · 763 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001401923, 1401923, edgar:1401923
Also known as MAP Pharmaceuticals, Inc.